KMB vs. ABT
KMB (Kimberly-Clark Corporation) and ABT (Abbott Laboratories) are both stocks. KMB operates in Household & Personal Products (Consumer Defensive), while ABT operates in Medical Devices (Healthcare). Over the past 10 years, KMB returned 1.74%/yr vs 10.97%/yr for ABT. Their 0.33 correlation means their historical movements had little consistent relationship.
Performance
KMB vs. ABT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KMB achieves a 11.19% return, which is significantly higher than ABT's -14.07% return. Over the past 10 years, KMB has underperformed ABT with an annualized return of 1.74%, while ABT has yielded a comparatively higher 10.97% annualized return.
KMB
- 1D
- -0.80%
- 1M
- -1.91%
- 6M
- 12.19%
- YTD
- 11.19%
- 1Y
- -7.99%
- 3Y*
- -1.48%
- 5Y*
- -0.50%
- 10Y*
- 1.74%
- ALL TIME*
- 10.90%
ABT
- 1D
- 0.09%
- 1M
- 15.48%
- 6M
- -1.99%
- YTD
- -14.07%
- 1Y
- -14.30%
- 3Y*
- 0.59%
- 5Y*
- -0.75%
- 10Y*
- 10.97%
- ALL TIME*
- 12.78%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.15B | $1.25B | $1.20B | |
| $325.44M | $393.74M | $451.43M |
KMB vs. ABT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
KMB Kimberly-Clark Corporation | 11.19% | -19.86% | 11.79% | -7.08% | -1.58% | 9.66% | 0.95% | 24.57% | -2.06% | 9.04% |
ABT Abbott Laboratories | -14.07% | 12.87% | 4.81% | 2.26% | -20.68% | 30.53% | 28.04% | 22.08% | 29.06% | 52.03% |
Correlation
The correlation between KMB and ABT is 0.38, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.38 |
Correlation (3Y) Balances recent behavior with more history. | 0.41 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.42 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.34 |
Correlation (All Time) Calculated using the full available price history since Dec 17, 1984 | 0.33 |
Fundamentals
KMB:
$36.28B
ABT:
$184.11B
KMB:
$5.93
ABT:
$3.11
KMB:
18.44
ABT:
34.03
KMB:
3.19
ABT:
2.12
KMB:
2.20
ABT:
3.96
KMB:
20.28
ABT:
2.82
KMB:
$16.54B
ABT:
$46.59B
KMB:
$5.93B
ABT:
$26.46B
KMB:
$3.07B
ABT:
$9.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KMB vs. ABT — Risk / Return Rank
KMB
ABT
KMB vs. ABT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kimberly-Clark Corporation (KMB) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KMB | ABT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.25 | ||
| Sortino ratioReturn per unit of downside risk | +0.42 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 0.92 | +0.05 |
| Calmar ratioReturn relative to maximum drawdown | -0.27 | -0.37 | +0.10 |
| Martin ratioReturn relative to average drawdown | -0.39 | -0.71 | +0.32 |
Loading charts...
Drawdowns
KMB vs. ABT - Drawdown Comparison
The maximum KMB drawdown since its inception was -36.97%, smaller than the maximum ABT drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for KMB and ABT.
Loading charts...
Drawdown Indicators
| KMB | ABT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -36.97% | -45.66% | +8.69% |
Max Drawdown (1Y)Largest decline over 1 year | -29.60% | -38.61% | +9.01% |
Max Drawdown (3Y)Largest decline over 3 years | -34.06% | -39.64% | +5.58% |
Max Drawdown (5Y)Largest decline over 5 years | -34.06% | -39.64% | +5.58% |
Max Drawdown (10Y)Largest decline over 10 years | -34.06% | -39.64% | +5.58% |
Current DrawdownCurrent decline from peak | -21.48% | -22.17% | +0.69% |
Average DrawdownAverage peak-to-trough decline | -8.89% | -10.90% | +2.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.31% | 20.16% | +0.15% |
Volatility
KMB vs. ABT - Volatility Comparison
The current volatility for Kimberly-Clark Corporation (KMB) is 8.53%, while Abbott Laboratories (ABT) has a volatility of 12.65%. This indicates that KMB experiences smaller price fluctuations and is considered to be less risky than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KMB | ABT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.53% | 12.65% | -4.12% |
Volatility (6M)Calculated over the trailing 6-month period | 18.63% | 21.13% | -2.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.16% | 26.55% | +0.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.63% | 22.89% | -2.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.25% | 23.95% | -2.70% |
Dividends
KMB vs. ABT - Dividend Comparison
KMB's dividend yield for the trailing twelve months is around 4.65%, more than ABT's 2.35% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 2.35% | 1.88% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% |
KMB Kimberly-Clark Corporation | 4.65% | 5.00% | 3.72% | 3.88% | 3.42% | 3.19% | 3.17% | 3.00% | 3.51% | 3.22% | 3.22% | 2.77% |
Financials
KMB vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Kimberly-Clark Corporation and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KMB vs. ABT - Profitability Comparison
KMB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Kimberly-Clark Corporation reported a gross profit of 1.53B and revenue of 4.16B. Therefore, the gross margin over that period was 36.9%.
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Abbott Laboratories reported a gross profit of 7.30B and revenue of 12.59B. Therefore, the gross margin over that period was 58.0%.
KMB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Kimberly-Clark Corporation reported an operating income of 753.00M and revenue of 4.16B, resulting in an operating margin of 18.1%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Abbott Laboratories reported an operating income of 1.78B and revenue of 12.59B, resulting in an operating margin of 14.2%.
KMB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Kimberly-Clark Corporation reported a net income of 521.00M and revenue of 4.16B, resulting in a net margin of 12.5%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Abbott Laboratories reported a net income of 928.00M and revenue of 12.59B, resulting in a net margin of 7.4%.
Frequently Asked Questions
KMB and ABT have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABT has higher volatility (12.65%) compared to KMB (8.53%). In terms of maximum drawdown, KMB dropped -36.97% vs ABT's -45.66%.
KMB currently has the higher Sharpe Ratio (-0.30 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KMB and ABT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer